Rex M. Pillai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rex M. Pillai has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Amirtahà Taebi
Department of Bioengineering, Lehigh University, Bethlehem, USA
1 shared publication - Bahman S. Roudsari
Kaiser Permanente Northern California, Oakland, CA 94612, USA
1 shared publication - Catherine T. Vu
Department of Radiology, University of California Davis, 4860 Y Street, Suite 3100, Sacramento, CA 95817, USA
1 shared publication - Emilie Roncali
Department of Biomedical Engineering, University of California - Davis, One Shields Avenue, Davis, CA 95616, Davis, California, 95616, UNITED STATES
1 shared publication - Maria del Pilar Bayona Molano
Interventional Radiology, Miller School of Medicine, University of Miami, 1120 NW 14th St Ste, Miami, FL, 33136, USA.
1 shared publication Ryan T. Di Geronimo
Department of Diagnostic & Interventional Radiology, University of California—Davis Medical Center, Sacramento, California
1 shared publication
Latest Publications
- Open Access
- 29 June 2020
- Published by MDPI AG in Bioengineering
- Vol. 7 (3) , 64
Computational Modeling of the Liver Arterial Blood Flow for Microsphere Therapy: Effect of Boundary Conditions
Transarterial embolization is a minimally invasive treatment for advanced liver cancer using microspheres loaded with a chemotherapeutic drug or radioactive yttrium-90 (90Y) that are injected into the hepatic arterial tree through a catheter. For personalized treatment, the microsphere distribution in the liver should be optimized through the injection volume and location. Computational fluid dynamics (CFD) simulations of the blood flow in the hepatic artery can help estimate this distribution if carefully parameterized. An important aspect is the choice of the boundary conditions imposed at the inlet and outlets of the computational domain. In this study, the effect of boundary conditions on the hepatic arterial tree hemodynamics was investigated. The outlet boundary conditions were modeled with three-element Windkessel circuits, representative of the downstream vasculature resistance. Results demonstrated that the downstream vasculature resistance affected the hepatic artery hemodynamics such as the velocity field, the pressure field and the blood flow streamline trajectories. Moreover, the number of microspheres received by the tumor significantly changed (more than 10% of the total injected microspheres) with downstream resistance variations. These findings suggest that patient-specific boundary conditions should be used in order to achieve a more accurate drug distribution estimation with CFD in transarterial embolization treatment planning.
- 29 June 2020
- Published by MDPI AG in Bioengineering
- Vol. 7 (3) , 64
Open AccessComputational Modeling of the Liver Arterial Blood Flow for Microsphere Therapy: Effect of Boundary Conditions
Transarterial embolization is a minimally invasive treatment for advanced liver cancer using microspheres loaded with a chemotherapeutic drug or radioactive yttrium-90 (90Y) that are injected into the hepatic arterial tree through a catheter. For personalized treatment, the microsphere distribution in the liver should be optimized through the injection volume and location. Computational fluid dynamics (CFD) simulations of the blood flow in the hepatic artery can help estimate this distribution if carefully parameterized. An important aspect is the choice of the boundary conditions imposed at the inlet and outlets of the computational domain. In this study, the effect of boundary conditions on the hepatic arterial tree hemodynamics was investigated. The outlet boundary conditions were modeled with three-element Windkessel circuits, representative of the downstream vasculature resistance. Results demonstrated that the downstream vasculature resistance affected the hepatic artery hemodynamics such as the velocity field, the pressure field and the blood flow streamline trajectories. Moreover, the number of microspheres received by the tumor significantly changed (more than 10% of the total injected microspheres) with downstream resistance variations. These findings suggest that patient-specific boundary conditions should be used in order to achieve a more accurate drug distribution estimation with CFD in transarterial embolization treatment planning.
- 2 March 2020
- Published by Georg Thieme Verlag KG in Digestive Disease Interventions
- Vol. 04 (01) , 091-100
Splenic Artery Embolization for Nonocclusive Hepatic Artery Hypoperfusion
Various minimally invasive, surgical, and laparoscopic interventions are performed for treatment and management of splenic artery steal syndrome in liver transplant and cirrhotic patients. Common approaches include splenic artery banding, ligation, stenting, and embolization to increase hepatic arterial flow. Splenic artery embolization has undergone further development to facilitate timely diagnosis, increase efficacy, decrease adverse outcomes, and improve patient selection. We review the current diagnostic modalities and technical advancements of splenic artery embolization to improve hepatic arterial perfusion in patients with splenic artery steal syndrome.
- 2 March 2020
- Published by Georg Thieme Verlag KG in Digestive Disease Interventions
- Vol. 04 (01) , 091-100
Splenic Artery Embolization for Nonocclusive Hepatic Artery Hypoperfusion
Various minimally invasive, surgical, and laparoscopic interventions are performed for treatment and management of splenic artery steal syndrome in liver transplant and cirrhotic patients. Common approaches include splenic artery banding, ligation, stenting, and embolization to increase hepatic arterial flow. Splenic artery embolization has undergone further development to facilitate timely diagnosis, increase efficacy, decrease adverse outcomes, and improve patient selection. We review the current diagnostic modalities and technical advancements of splenic artery embolization to improve hepatic arterial perfusion in patients with splenic artery steal syndrome.